This CME series focuses on improving the overall management of patients with GI disease. Faculty experts provide education that is designed to strengthen clinician skill-sets needed to provide not only better patient care —via enhanced diagnosis and management strategies—but also to optimize patient outcomes through strategies that are meant to improve therapeutic adherence.
Samuel J. Klempner, MD
PeerHow Can a Multidisciplinary Team Optimize Management of G/GEJ Cancer–Related Symptom Burden?
Yelena Janjigian, MD
PeerIntegrating Clinical Insights: Key G/GEJ Cancer Data Analyzed from the San Diego Oncology Conference
Samuel J. Klempner, MD
PeerWhat Is the Current Standard for First-Line Treatment of Metastatic HER2-Positive G/GEJ Cancers?
Yelena Janjigian, MD
PeerWhat Is the Current Standard for First-Line Treatment of Metastatic HER2-Negative G/GEJ Cancers?
Yelena Janjigian, MD
PeerYelena Janjigian, MD
PeerClaudin18.2: An Emerging Biomarker and Its Significance as a Therapeutic Target in G/GEJ Cancers
Samuel J. Klempner, MD
PeerYelena Janjigian, MD
PeerWhat Is the Evidence Supporting CLDN18.2 Targeting in Frontline Management of G/GEJ Cancers
Samuel J. Klempner, MD
Peer